Cardialen

Cardialen, Inc. is an early-stage medical device company developing implantable low-energy defibrillation and cardioversion therapies to treat dangerous rapid heart rhythms, including ventricular tachycardia and ventricular fibrillation, in addition to atrial fibrillation. Cardialen’s MultiPulse Therapy™ (MPT™) uses a patented sequence of low-energy pulses to restore normal heart rhythm, offering a gentler alternative to the high-energy (often painful) shocks used for atrial fibrillation and ventricular fibrillation.